InsiderTrades

Form 4 for ELV Elevance Health

Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001156039-22-000020 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-03-03 2022-03-01 ELV Todt Blair Williams EVP, CLO F - Tax $451.50 -191 2,534 -7% -$86.2K
D 2022-03-03 2022-03-01 ELV Todt Blair Williams EVP, CLO A - Grant $0.00 +1,883 4,417 +74% $0
D 2022-03-03 2022-03-01 ELV Todt Blair Williams EVP, CLO A - Grant $0.00 +7,508 7,508 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-03-01 F D 191 $451.50 2,534 D — — (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
2 Common Common Stock 2022-03-01 A A 1,883 $0.00 4,417 D — — (F2) Represents restricted share units. Restrictions lapse as follows: 627 shares on 3/1/2023, and 628 shares each on 3/1/2024 and 3/1/2025.
3 Derivative Employee Stock Option (Right to Buy) 2022-03-01 A A 7,508 $0.00 7,508 D $451.50 · — to 2032-03-01 7,508 Common Stock (F3) The option represents a right to purchase a total of 7,508 shares, and is exercisable in three annual installments, with one installment of 2,502 shares and two installments of 2,503 shares each, beginning on 3/1/2023, which is the one-year anniversary of the option grant date.